0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Small Molecule Cancer Drug Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-2V9651
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Small Molecule Cancer Drug Market Insights and Forecast to 2028

Global Small Molecule Cancer Drug Market Insights and Forecast to 2028

Code: QYRE-Auto-2V9651
Report
January 2022
96 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Market Analysis and Insights: Global Small Molecule Cancer Drug Market

Due to the COVID-19 pandemic, the global Small Molecule Cancer Drug market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Cytokine accounting for % of the Small Molecule Cancer Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Lymphoma segment is altered to an % CAGR throughout this forecast period.
China Small Molecule Cancer Drug market size is valued at US$ million in 2021, while the US and Europe Small Molecule Cancer Drug are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Small Molecule Cancer Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Small Molecule Cancer Drug include Bayer, Cadila Pharmaceutical, Astrazeneca, Johnson & Johnson, Eli Lily, Boehringer, Roche, Merck and Novartis. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Small Molecule Cancer Drug Scope and Segment
Small Molecule Cancer Drug market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Small Molecule Cancer Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Cytokine
Humanized Monoclonal Antiboby
Others

Segment by Application

Lymphoma
Myeloma
Prostate Cancer
Others

BY COMPANY

Bayer
Cadila Pharmaceutical
Astrazeneca
Johnson & Johnson
Eli Lily
Boehringer
Roche
Merck
Novartis

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Small Molecule Cancer Drug Product Introduction
1.2 Market by Type
1.2.1 Global Small Molecule Cancer Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Cytokine
1.2.3 Humanized Monoclonal Antiboby
1.2.4 Others
1.3 Market by Application
1.3.1 Global Small Molecule Cancer Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Lymphoma
1.3.3 Myeloma
1.3.4 Prostate Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Small Molecule Cancer Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Small Molecule Cancer Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Small Molecule Cancer Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Small Molecule Cancer Drug Sales by Region
2.4.1 Global Small Molecule Cancer Drug Sales by Region (2017-2022)
2.4.2 Global Sales Small Molecule Cancer Drug by Region (2023-2028)
2.5 Global Small Molecule Cancer Drug Revenue by Region
2.5.1 Global Small Molecule Cancer Drug Revenue by Region (2017-2022)
2.5.2 Global Small Molecule Cancer Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Small Molecule Cancer Drug Sales by Manufacturers
3.1.1 Global Top Small Molecule Cancer Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Small Molecule Cancer Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Small Molecule Cancer Drug in 2021
3.2 Global Small Molecule Cancer Drug Revenue by Manufacturers
3.2.1 Global Small Molecule Cancer Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Small Molecule Cancer Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Small Molecule Cancer Drug Revenue in 2021
3.3 Global Small Molecule Cancer Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Small Molecule Cancer Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Small Molecule Cancer Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Small Molecule Cancer Drug Sales by Type
4.1.1 Global Small Molecule Cancer Drug Historical Sales by Type (2017-2022)
4.1.2 Global Small Molecule Cancer Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Small Molecule Cancer Drug Sales Market Share by Type (2017-2028)
4.2 Global Small Molecule Cancer Drug Revenue by Type
4.2.1 Global Small Molecule Cancer Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Small Molecule Cancer Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Small Molecule Cancer Drug Revenue Market Share by Type (2017-2028)
4.3 Global Small Molecule Cancer Drug Price by Type
4.3.1 Global Small Molecule Cancer Drug Price by Type (2017-2022)
4.3.2 Global Small Molecule Cancer Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Small Molecule Cancer Drug Sales by Application
5.1.1 Global Small Molecule Cancer Drug Historical Sales by Application (2017-2022)
5.1.2 Global Small Molecule Cancer Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Small Molecule Cancer Drug Sales Market Share by Application (2017-2028)
5.2 Global Small Molecule Cancer Drug Revenue by Application
5.2.1 Global Small Molecule Cancer Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Small Molecule Cancer Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Small Molecule Cancer Drug Revenue Market Share by Application (2017-2028)
5.3 Global Small Molecule Cancer Drug Price by Application
5.3.1 Global Small Molecule Cancer Drug Price by Application (2017-2022)
5.3.2 Global Small Molecule Cancer Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Small Molecule Cancer Drug Market Size by Type
6.1.1 North America Small Molecule Cancer Drug Sales by Type (2017-2028)
6.1.2 North America Small Molecule Cancer Drug Revenue by Type (2017-2028)
6.2 North America Small Molecule Cancer Drug Market Size by Application
6.2.1 North America Small Molecule Cancer Drug Sales by Application (2017-2028)
6.2.2 North America Small Molecule Cancer Drug Revenue by Application (2017-2028)
6.3 North America Small Molecule Cancer Drug Market Size by Country
6.3.1 North America Small Molecule Cancer Drug Sales by Country (2017-2028)
6.3.2 North America Small Molecule Cancer Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Small Molecule Cancer Drug Market Size by Type
7.1.1 Europe Small Molecule Cancer Drug Sales by Type (2017-2028)
7.1.2 Europe Small Molecule Cancer Drug Revenue by Type (2017-2028)
7.2 Europe Small Molecule Cancer Drug Market Size by Application
7.2.1 Europe Small Molecule Cancer Drug Sales by Application (2017-2028)
7.2.2 Europe Small Molecule Cancer Drug Revenue by Application (2017-2028)
7.3 Europe Small Molecule Cancer Drug Market Size by Country
7.3.1 Europe Small Molecule Cancer Drug Sales by Country (2017-2028)
7.3.2 Europe Small Molecule Cancer Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Small Molecule Cancer Drug Market Size by Type
8.1.1 Asia Pacific Small Molecule Cancer Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Small Molecule Cancer Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Small Molecule Cancer Drug Market Size by Application
8.2.1 Asia Pacific Small Molecule Cancer Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Small Molecule Cancer Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Small Molecule Cancer Drug Market Size by Region
8.3.1 Asia Pacific Small Molecule Cancer Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Small Molecule Cancer Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Small Molecule Cancer Drug Market Size by Type
9.1.1 Latin America Small Molecule Cancer Drug Sales by Type (2017-2028)
9.1.2 Latin America Small Molecule Cancer Drug Revenue by Type (2017-2028)
9.2 Latin America Small Molecule Cancer Drug Market Size by Application
9.2.1 Latin America Small Molecule Cancer Drug Sales by Application (2017-2028)
9.2.2 Latin America Small Molecule Cancer Drug Revenue by Application (2017-2028)
9.3 Latin America Small Molecule Cancer Drug Market Size by Country
9.3.1 Latin America Small Molecule Cancer Drug Sales by Country (2017-2028)
9.3.2 Latin America Small Molecule Cancer Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Small Molecule Cancer Drug Market Size by Type
10.1.1 Middle East and Africa Small Molecule Cancer Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Small Molecule Cancer Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Small Molecule Cancer Drug Market Size by Application
10.2.1 Middle East and Africa Small Molecule Cancer Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Small Molecule Cancer Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Small Molecule Cancer Drug Market Size by Country
10.3.1 Middle East and Africa Small Molecule Cancer Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Small Molecule Cancer Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Overview
11.1.3 Bayer Small Molecule Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer Small Molecule Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 Cadila Pharmaceutical
11.2.1 Cadila Pharmaceutical Corporation Information
11.2.2 Cadila Pharmaceutical Overview
11.2.3 Cadila Pharmaceutical Small Molecule Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Cadila Pharmaceutical Small Molecule Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cadila Pharmaceutical Recent Developments
11.3 Astrazeneca
11.3.1 Astrazeneca Corporation Information
11.3.2 Astrazeneca Overview
11.3.3 Astrazeneca Small Molecule Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Astrazeneca Small Molecule Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Astrazeneca Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson Small Molecule Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Johnson & Johnson Small Molecule Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Johnson & Johnson Recent Developments
11.5 Eli Lily
11.5.1 Eli Lily Corporation Information
11.5.2 Eli Lily Overview
11.5.3 Eli Lily Small Molecule Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Eli Lily Small Molecule Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eli Lily Recent Developments
11.6 Boehringer
11.6.1 Boehringer Corporation Information
11.6.2 Boehringer Overview
11.6.3 Boehringer Small Molecule Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Boehringer Small Molecule Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Boehringer Recent Developments
11.7 Roche
11.7.1 Roche Corporation Information
11.7.2 Roche Overview
11.7.3 Roche Small Molecule Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Roche Small Molecule Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Roche Recent Developments
11.8 Merck
11.8.1 Merck Corporation Information
11.8.2 Merck Overview
11.8.3 Merck Small Molecule Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Merck Small Molecule Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merck Recent Developments
11.9 Novartis
11.9.1 Novartis Corporation Information
11.9.2 Novartis Overview
11.9.3 Novartis Small Molecule Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Novartis Small Molecule Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Novartis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Small Molecule Cancer Drug Industry Chain Analysis
12.2 Small Molecule Cancer Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Small Molecule Cancer Drug Production Mode & Process
12.4 Small Molecule Cancer Drug Sales and Marketing
12.4.1 Small Molecule Cancer Drug Sales Channels
12.4.2 Small Molecule Cancer Drug Distributors
12.5 Small Molecule Cancer Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Small Molecule Cancer Drug Industry Trends
13.2 Small Molecule Cancer Drug Market Drivers
13.3 Small Molecule Cancer Drug Market Challenges
13.4 Small Molecule Cancer Drug Market Restraints
14 Key Findings in The Global Small Molecule Cancer Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Small Molecule Cancer Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Cytokine
    Table 3. Major Manufacturers of Humanized Monoclonal Antiboby
    Table 4. Major Manufacturers of Others
    Table 5. Global Small Molecule Cancer Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Small Molecule Cancer Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Small Molecule Cancer Drug Sales by Region (2017-2022) & (K Units)
    Table 8. Global Small Molecule Cancer Drug Sales Market Share by Region (2017-2022)
    Table 9. Global Small Molecule Cancer Drug Sales by Region (2023-2028) & (K Units)
    Table 10. Global Small Molecule Cancer Drug Sales Market Share by Region (2023-2028)
    Table 11. Global Small Molecule Cancer Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Small Molecule Cancer Drug Revenue Market Share by Region (2017-2022)
    Table 13. Global Small Molecule Cancer Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Small Molecule Cancer Drug Revenue Market Share by Region (2023-2028)
    Table 15. Global Small Molecule Cancer Drug Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Small Molecule Cancer Drug Sales Share by Manufacturers (2017-2022)
    Table 17. Global Small Molecule Cancer Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Small Molecule Cancer Drug Revenue Share by Manufacturers (2017-2022)
    Table 19. Small Molecule Cancer Drug Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Small Molecule Cancer Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Small Molecule Cancer Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Cancer Drug as of 2021)
    Table 22. Small Molecule Cancer Drug Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Small Molecule Cancer Drug Product Offered
    Table 24. Date of Manufacturers Enter into Small Molecule Cancer Drug Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Small Molecule Cancer Drug Sales by Type (2017-2022) & (K Units)
    Table 27. Global Small Molecule Cancer Drug Sales by Type (2023-2028) & (K Units)
    Table 28. Global Small Molecule Cancer Drug Sales Share by Type (2017-2022)
    Table 29. Global Small Molecule Cancer Drug Sales Share by Type (2023-2028)
    Table 30. Global Small Molecule Cancer Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Small Molecule Cancer Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Small Molecule Cancer Drug Revenue Share by Type (2017-2022)
    Table 33. Global Small Molecule Cancer Drug Revenue Share by Type (2023-2028)
    Table 34. Small Molecule Cancer Drug Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Small Molecule Cancer Drug Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Small Molecule Cancer Drug Sales by Application (2017-2022) & (K Units)
    Table 37. Global Small Molecule Cancer Drug Sales by Application (2023-2028) & (K Units)
    Table 38. Global Small Molecule Cancer Drug Sales Share by Application (2017-2022)
    Table 39. Global Small Molecule Cancer Drug Sales Share by Application (2023-2028)
    Table 40. Global Small Molecule Cancer Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Small Molecule Cancer Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Small Molecule Cancer Drug Revenue Share by Application (2017-2022)
    Table 43. Global Small Molecule Cancer Drug Revenue Share by Application (2023-2028)
    Table 44. Small Molecule Cancer Drug Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Small Molecule Cancer Drug Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Small Molecule Cancer Drug Sales by Type (2017-2022) & (K Units)
    Table 47. North America Small Molecule Cancer Drug Sales by Type (2023-2028) & (K Units)
    Table 48. North America Small Molecule Cancer Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Small Molecule Cancer Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Small Molecule Cancer Drug Sales by Application (2017-2022) & (K Units)
    Table 51. North America Small Molecule Cancer Drug Sales by Application (2023-2028) & (K Units)
    Table 52. North America Small Molecule Cancer Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Small Molecule Cancer Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Small Molecule Cancer Drug Sales by Country (2017-2022) & (K Units)
    Table 55. North America Small Molecule Cancer Drug Sales by Country (2023-2028) & (K Units)
    Table 56. North America Small Molecule Cancer Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Small Molecule Cancer Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Small Molecule Cancer Drug Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Small Molecule Cancer Drug Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Small Molecule Cancer Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Small Molecule Cancer Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Small Molecule Cancer Drug Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Small Molecule Cancer Drug Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Small Molecule Cancer Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Small Molecule Cancer Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Small Molecule Cancer Drug Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Small Molecule Cancer Drug Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Small Molecule Cancer Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Small Molecule Cancer Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Small Molecule Cancer Drug Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Small Molecule Cancer Drug Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Small Molecule Cancer Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Small Molecule Cancer Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Small Molecule Cancer Drug Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Small Molecule Cancer Drug Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Small Molecule Cancer Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Small Molecule Cancer Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Small Molecule Cancer Drug Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Small Molecule Cancer Drug Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Small Molecule Cancer Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Small Molecule Cancer Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Small Molecule Cancer Drug Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Small Molecule Cancer Drug Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Small Molecule Cancer Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Small Molecule Cancer Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Small Molecule Cancer Drug Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Small Molecule Cancer Drug Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Small Molecule Cancer Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Small Molecule Cancer Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Small Molecule Cancer Drug Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Small Molecule Cancer Drug Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Small Molecule Cancer Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Small Molecule Cancer Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Small Molecule Cancer Drug Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Small Molecule Cancer Drug Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Small Molecule Cancer Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Small Molecule Cancer Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Small Molecule Cancer Drug Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Small Molecule Cancer Drug Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Small Molecule Cancer Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Small Molecule Cancer Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Small Molecule Cancer Drug Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Small Molecule Cancer Drug Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Small Molecule Cancer Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Small Molecule Cancer Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Bayer Corporation Information
    Table 107. Bayer Description and Major Businesses
    Table 108. Bayer Small Molecule Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Bayer Small Molecule Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Bayer Recent Developments
    Table 111. Cadila Pharmaceutical Corporation Information
    Table 112. Cadila Pharmaceutical Description and Major Businesses
    Table 113. Cadila Pharmaceutical Small Molecule Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Cadila Pharmaceutical Small Molecule Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Cadila Pharmaceutical Recent Developments
    Table 116. Astrazeneca Corporation Information
    Table 117. Astrazeneca Description and Major Businesses
    Table 118. Astrazeneca Small Molecule Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Astrazeneca Small Molecule Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Astrazeneca Recent Developments
    Table 121. Johnson & Johnson Corporation Information
    Table 122. Johnson & Johnson Description and Major Businesses
    Table 123. Johnson & Johnson Small Molecule Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Johnson & Johnson Small Molecule Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Johnson & Johnson Recent Developments
    Table 126. Eli Lily Corporation Information
    Table 127. Eli Lily Description and Major Businesses
    Table 128. Eli Lily Small Molecule Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. Eli Lily Small Molecule Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Eli Lily Recent Developments
    Table 131. Boehringer Corporation Information
    Table 132. Boehringer Description and Major Businesses
    Table 133. Boehringer Small Molecule Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Boehringer Small Molecule Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Boehringer Recent Developments
    Table 136. Roche Corporation Information
    Table 137. Roche Description and Major Businesses
    Table 138. Roche Small Molecule Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. Roche Small Molecule Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Roche Recent Developments
    Table 141. Merck Corporation Information
    Table 142. Merck Description and Major Businesses
    Table 143. Merck Small Molecule Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. Merck Small Molecule Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Merck Recent Developments
    Table 146. Novartis Corporation Information
    Table 147. Novartis Description and Major Businesses
    Table 148. Novartis Small Molecule Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. Novartis Small Molecule Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Novartis Recent Developments
    Table 151. Key Raw Materials Lists
    Table 152. Raw Materials Key Suppliers Lists
    Table 153. Small Molecule Cancer Drug Distributors List
    Table 154. Small Molecule Cancer Drug Customers List
    Table 155. Small Molecule Cancer Drug Market Trends
    Table 156. Small Molecule Cancer Drug Market Drivers
    Table 157. Small Molecule Cancer Drug Market Challenges
    Table 158. Small Molecule Cancer Drug Market Restraints
    Table 159. Research Programs/Design for This Report
    Table 160. Key Data Information from Secondary Sources
    Table 161. Key Data Information from Primary Sources
List of Figures
    Figure 1. Small Molecule Cancer Drug Product Picture
    Figure 3. Global Small Molecule Cancer Drug Market Share by Type in 2021 & 2028
    Figure 3. Cytokine Product Picture
    Figure 4. Humanized Monoclonal Antiboby Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Small Molecule Cancer Drug Market Share by Application in 2021 & 2028
    Figure 7. Lymphoma
    Figure 8. Myeloma
    Figure 9. Prostate Cancer
    Figure 10. Others
    Figure 11. Small Molecule Cancer Drug Report Years Considered
    Figure 12. Global Small Molecule Cancer Drug Sales 2017-2028 (K Units)
    Figure 13. Global Small Molecule Cancer Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Small Molecule Cancer Drug Revenue 2017-2028 (US$ Million)
    Figure 15. Global Small Molecule Cancer Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Small Molecule Cancer Drug Sales Market Share by Region (2017-2022)
    Figure 17. Global Small Molecule Cancer Drug Sales Market Share by Region (2023-2028)
    Figure 18. North America Small Molecule Cancer Drug Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Small Molecule Cancer Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Small Molecule Cancer Drug Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Small Molecule Cancer Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Small Molecule Cancer Drug Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Small Molecule Cancer Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Small Molecule Cancer Drug Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Small Molecule Cancer Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Small Molecule Cancer Drug Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Small Molecule Cancer Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Small Molecule Cancer Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Small Molecule Cancer Drug in the World: Market Share by Small Molecule Cancer Drug Revenue in 2021
    Figure 30. Global Small Molecule Cancer Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Small Molecule Cancer Drug Sales Market Share by Type (2017-2028)
    Figure 32. Global Small Molecule Cancer Drug Revenue Market Share by Type (2017-2028)
    Figure 33. Global Small Molecule Cancer Drug Sales Market Share by Application (2017-2028)
    Figure 34. Global Small Molecule Cancer Drug Revenue Market Share by Application (2017-2028)
    Figure 35. North America Small Molecule Cancer Drug Sales Market Share by Type (2017-2028)
    Figure 36. North America Small Molecule Cancer Drug Revenue Market Share by Type (2017-2028)
    Figure 37. North America Small Molecule Cancer Drug Sales Market Share by Application (2017-2028)
    Figure 38. North America Small Molecule Cancer Drug Revenue Market Share by Application (2017-2028)
    Figure 39. North America Small Molecule Cancer Drug Sales Share by Country (2017-2028)
    Figure 40. North America Small Molecule Cancer Drug Revenue Share by Country (2017-2028)
    Figure 41. U.S. Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Small Molecule Cancer Drug Sales Market Share by Type (2017-2028)
    Figure 44. Europe Small Molecule Cancer Drug Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Small Molecule Cancer Drug Sales Market Share by Application (2017-2028)
    Figure 46. Europe Small Molecule Cancer Drug Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Small Molecule Cancer Drug Sales Share by Country (2017-2028)
    Figure 48. Europe Small Molecule Cancer Drug Revenue Share by Country (2017-2028)
    Figure 49. Germany Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 50. France Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Small Molecule Cancer Drug Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Small Molecule Cancer Drug Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Small Molecule Cancer Drug Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Small Molecule Cancer Drug Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Small Molecule Cancer Drug Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Small Molecule Cancer Drug Revenue Share by Region (2017-2028)
    Figure 60. China Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 63. India Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Small Molecule Cancer Drug Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Small Molecule Cancer Drug Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Small Molecule Cancer Drug Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Small Molecule Cancer Drug Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Small Molecule Cancer Drug Sales Share by Country (2017-2028)
    Figure 75. Latin America Small Molecule Cancer Drug Revenue Share by Country (2017-2028)
    Figure 76. Mexico Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Small Molecule Cancer Drug Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Small Molecule Cancer Drug Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Small Molecule Cancer Drug Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Small Molecule Cancer Drug Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Small Molecule Cancer Drug Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Small Molecule Cancer Drug Revenue Share by Country (2017-2028)
    Figure 85. Turkey Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 87. U.A.E Small Molecule Cancer Drug Revenue (2017-2028) & (US$ Million)
    Figure 88. Small Molecule Cancer Drug Value Chain
    Figure 89. Small Molecule Cancer Drug Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network

RELATED REPORTS

Global Barium Titanium Oxide Market Insights Forecast to 2028
Global Barium Titanium Oxide Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-9Z7409
Wed May 18 00:00:00 UTC 2022

Add to Cart

Global Aspetic Negative Pressure Pharmaceutical Isolators Market Insights Forecast to 2028
Global Aspetic Negative Pressure Pharmaceutical Isolators Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-0T7466
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Chemical API Market Insights and Forecast to 2028
Global Chemical API Market Insights and Forecast to 2028

Market Analysis and Insights Global Chemical API MarketThe global Chemical API market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.Fully considering the economic change by this health crisis Bulk API accounting for of the Chemical API global market in 2021 is projected to value US million by 2028 growing at a revised CAGR in the postCOVID19 period.

120 Pages
Type: Report
Code: QYRE-Auto-28A10066
Tue May 03 00:00:00 UTC 2022

Add to Cart